Insider Transactions

What Finch Therapeutics Group, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Smisek Jeffrey A	Director	Jun 07	Gift · G	−383	—	—	24,383
Smisek Jeffrey A	Director	Jun 07	Gift · G	−384	—	—	17,870
Smisek Jeffrey A	Director	May 20	Gift · G	−3,750	—	—	0
Smisek Jeffrey A	Director	Mar 28	Open-market sale · S	−1,600	$2.61	−$4.18K	6,512
Smisek Jeffrey A	Director	Mar 28	Open-market sale · S	−6,642	$2.57	−$17.1K	0
Smisek Jeffrey A	Director	Nov 22	Open-market sale · S	−1,470	$3.64	−$5.35K	6,642
Graf Susan E	Director	Jun 09	Open-market buy · P	+5,010	$0.27	+$1.35K	5,010
Blaustein Marc	Chief Operating Officer	Feb 21	Sale for tax withholding · S	−4,619	$0.38	−$1.76K	27,995
Vittiglio Joseph	Chief Business & Legal Officer	Oct 21	Sale for tax withholding · S	−3,636	$1.39	−$5.05K	31,364
Blaustein Marc	Chief Operating Officer	Oct 21	Sale for tax withholding · S	−3,636	$1.39	−$5.05K	32,614
Vittiglio Joseph	Chief Business & Legal Officer	Jun 13	Grant / award · A	+35,000	—	—	35,000
Blaustein Marc	Chief Operating Officer	Jun 13	Grant / award · A	+35,000	—	—	36,250
Haft Nicholas	Director	Dec 20	Open-market buy · P	+63,850	$10.18	+$650K	4,056,907
Ferrante Domenic J	Director	Mar 23	Open-market buy · P	+102,941	$17.00	+$1.75M	636,195
Ferrante Domenic J	Director	Mar 23	Derivative Conversion · C	+90,378	—	—	533,254
Ferrante Domenic J	Director	Mar 23	Derivative Conversion · C	+300,948	—	—	442,876
Ferrante Domenic J	Director	Mar 23	Derivative Conversion · C	+141,928	—	—	141,928
Smisek Jeffrey A	Director	Mar 23	Open-market buy · P	+88,235	$17.00	+$1.5M	1,694,541
Smisek Jeffrey A	Director	Mar 23	Derivative Conversion · C	+272,245	—	—	1,606,306
Smisek Jeffrey A	Director	Mar 23	Derivative Conversion · C	+297,178	—	—	1,334,061

Page 1 of 2 · showing the 20 most recent Sign up free to view all 31 transactions and filter by insider →

Comments